Production (Stage)
Pharming Group N.V.
PHGUF
$1.19
$0.18518.50%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Net Income | 90.22% | -298.59% | -190.16% | ||
| Total Depreciation and Amortization | -104.95% | 237.38% | -39.52% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -3,268.06% | -100.54% | 679.42% | ||
| Change in Net Operating Assets | -785.97% | 24.28% | 69.68% | ||
| Cash from Operations | -72.89% | -166.05% | 228.24% | ||
| Capital Expenditure | -167.50% | 73.68% | -106.80% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 4,820.43% | 120.64% | 93.79% | ||
| Cash from Investing | 5,381.02% | 116.99% | 93.29% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -13,022.92% | -441.36% | 81.03% | ||
| Issuance of Common Stock | 191.63% | 249.41% | -97.04% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 100.30% | -114.51% | 52.94% | ||
| Cash from Financing | -1,045.45% | -142.25% | -119.47% | ||
| Foreign Exchange rate Adjustments | 196.46% | -189.98% | 148.08% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 51.77% | -238.95% | 114.07% | ||